More Business Briefs
- Business briefs: Pfizer, Novartis, Boehringer Ingelheim, Elsevier
- Business Briefs: inVentiv; Mylan; Royalty Pharma; Pfizer; Edelman
- Business briefs: Actavis, Bayer, Oramed, Elan
- Business briefs: Pfizer, BMS, CMS, Sanofi
- Business briefs: Bayer, FDA, Ranbaxy
Santarus, a specialty pharmaceutical company focused on products treating gastrointestinal diseases, has launched a new full-service Web site to coincide with the launch of its new capsule formulation Zegerid, an immediate release oral proton pump inhibitor for nighttime acid control. The site, zegerid.com, was designed and developed by Compass Healthcare Communications.